The cost-utility of cinacalcet in addition to standard care compared to standard care alone for secondary hyperparathyroidism in end-stage renal disease: a UK perspective
2007 ◽
Vol 22
(5)
◽
pp. 1428-1436
◽
Keyword(s):
Keyword(s):
2013 ◽
Vol 126
(12)
◽
pp. e11-e12
◽
Keyword(s):
2001 ◽
Vol 11
(3)
◽
pp. 188-193
◽
2019 ◽
Vol 51
(7)
◽
pp. 1261-1270
◽
2010 ◽
Vol 24
(3)
◽
pp. 173
◽
2015 ◽
Vol 120
(2)
◽
pp. e19
Keyword(s):